GO
Loading...

Novartis AG

More

  • Bullish On Biotech Thursday, 31 Jul 2008 | 4:01 PM ET

    Bristol Myers offered a cool $4.5 billion for ImClone Thursday. Is now the time to play biotech?

  • Markets Best Sector Friday, 25 Jul 2008 | 6:52 PM ET

    In the last month healthcare has emerged as the best performing sector in the S&P. Are drug makers a cure for your portfolio in this economic downturn?

  • Big Pharma Is Scrambling To Buy More Biotech Firms Monday, 21 Jul 2008 | 11:11 AM ET

    Roche Holdings' $43.7 billion bid to buy the rest of Genentech highlights drugmakers' growing reliance on biotech products.

  • Roche Offers to Buy Out Genentech for $43.7 Billion Monday, 21 Jul 2008 | 6:33 AM ET

    Swiss drugmaker Roche Holding offered to acquire all outstanding shares in its U.S. partner Genentech for $43.7 billion in cash to reinforce its position in cancer medicines.

  • Web Extra: Beware Of Broken China? Thursday, 17 Jul 2008 | 7:00 PM ET

    In Thursday’s Web Extra the traders talk China – now growing at its slowest pace since 2005. Also Pete Najarian has more fun with Pharma.

  • Novartis Earnings Beat Forecasts, Dollar Helps Thursday, 17 Jul 2008 | 12:17 PM ET

    Second-quarter net profit at Novartis rose 17 percent to $2.27 billion, helped by the weak U.S. dollar and cost cutting efforts, beating forecasts and boosting its shares.

  • Your First Move For Thursday July 17th Wednesday, 16 Jul 2008 | 6:55 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Stocks Drop Into Official Bear Market Wednesday, 9 Jul 2008 | 6:06 PM ET

    The S&P closed 20% below its all-time high set in October, making it the last of the three major U.S. stock indexes to fall into a bear market. What's the "Word on the Street?"

  • Biopharma Analyst Musical Chairs Wednesday, 2 Jul 2008 | 11:16 AM ET

    In the world of nearly 400 publicly-traded biotechs, analyst coverage is especially important. Many of the firms are micro caps and when an analyst initiates coverage it can help put a baby biotech on investor and reporter radar screens.

  • Biotech A Bear Fighter? Tuesday, 1 Jul 2008 | 6:31 PM ET

    What are the best plays when the market enters bear territory?

  • 4 Morningstar Stock Picks Tuesday, 1 Jul 2008 | 11:14 AM ET

    Paul Larson says it's time to get back into equities. The equities strategist at Morningstar says buying stocks now will set up your portfolio for a big payoff in three to five years. Larson offered CNBC his top U.S. stocks.

  • A Hurry-Up Offense for the Second Half Monday, 30 Jun 2008 | 1:24 PM ET

    It was an ugly first half for the stock market and now that the goal posts have been moved for the economic recovery, expect a rough game in the second half.

  • Market Midterm: Healthcare Wednesday, 25 Jun 2008 | 6:30 PM ET

    Here's how you can play healthcare with either a McCain or Obama presidency!

  • Pops & Drops: Raytheon, Pulte... Tuesday, 24 Jun 2008 | 6:31 PM ET

    Following are the day’s biggest winners and losers. Find out why shares of Raytheon and Pulte popped while UPS and Cooper Tire dropped.

  • Banking On A Bottom? Tuesday, 24 Jun 2008 | 5:50 PM ET

    The Dow closed lower on Tuesday with stocks slipping on concerns about the economy after consumer confidence fell to a 16-year low. What's the "Word on the Street?"

  • Lilly Gets A Lift, Pfizer Goes Pfft Wednesday, 4 Jun 2008 | 3:05 PM ET

    Despite at least a couple of analysts coming out with relatively bullish post-ASCO research notes on Pfizer's oncology drug pipeline, PFE shares have fallen to yet another new low intra-day and have crossed another threshold.

  • Inflation, Credit Worries Dent Europe Stocks Tuesday, 27 May 2008 | 1:01 PM ET

    A bout of risk aversion dented European stocks on Tuesday as jitters grew over potential credit-related problems at banks and inflation, while typically defensive stocks such as pharmaceuticals and food rallied.

  • ASCO Countdown: Conference Season In Full Bloom Thursday, 15 May 2008 | 12:02 PM ET

    This is gonna be a crazy couple of days. At 9 pm ET tonight the American Society of Clinical Oncology is putting nearly 5,000 studies on its website all at once. Although ASCO says it's all about the science and protecting the "scientific integrity" of its upcoming conference, this is, frankly, an attempt to level the playing field for Wall Street.

  • Mars Acquisition of Wrigley: 3rd Biggest Deal of 2008 Monday, 28 Apr 2008 | 10:09 AM ET

    Mars confirmed that it is buying Wrigley's for $23B in partnership with Warren Buffett.  The deal would rank as the third biggest deal of the year.  Here are the top deals of year to date...

  • Clank of America Monday, 21 Apr 2008 | 6:17 PM ET

    The Dow pulled back Monday after a weaker-than-expected profit report from Bank of America stirred concerns about the health of corporate earnings. What's the "Word on The Street?"